Dr Emily He
Gastroenterologist and Hepatologist
BSc(Med) MBBS(Hons), MPH, FRACP, PhD
Dr Emily He is a consultant gastroenterologist and hepatologist who is highly experienced in all aspects of general gastroenterology, including bowel cancer screening and polyp removal, gastroesophageal reflux disease, peptic ulcer disease and functional gastrointestinal disorders.
She has a particular interest in liver disease, especially the management of viral hepatitis, fatty liver disease and liver cancer.
Dr He graduated from the University of NSW with honours in 2005. After completing her gastroenterology specialist training at Prince of Wales Hospital, she received a prestigious NHMRC and the White-Walker Cancer Research Scholarship to conduct doctoral research in bowel cancer screening at the University of NSW and the University of Oxford. She also completed a Churchill Fellowship to study emerging technologies and platforms in optimising bowel cancer screening. Dr He has authored numerous publications in bowel cancer screening and continues as a senior research fellow in bowel and liver cancer control at the University of Sydney.
Dr He is among the consultants responsible for overseeing the liver service at Concord Repatriation General Hospital and also leads the direct access colonoscopy service at the same institution.
She has rooms in Randwick and Burwood. She performs gastroscopy and colonoscopy at Strathfield Private Hospital, Prince of Wales Private Hospital, Double Bay Day Hospital and has public lists at Concord Repatriation General Hospital.
Areas of Expertise
- Bowel Cancer Screening
- Gastroesophageal Reflux Disease
- Peptic Ulcer Disease
- Functional GI Disorders - including IBS
- Liver Disease - viral hepatitis, fatty liver disease and liver cancer
Consulting Locations
- Randwick
Education
- Doctor of Philosophy (PhD) UNSW
- Fellow of the Royal Australasian College of Physicians (FRACP)
- Master of Public Health UNSW
- BSc(Med) and MBBS(Hons) UNSW
Memberships
- Member of the GESA Liver Clinical Research Network (CRN)
- Member of the Working Party for Roadmap for Liver Cancer Control in Australia
- Member of the Working Party for Cancer Council Australia Colorectal Cancer
Hospital Appointments
- Prince of Wales Private Hospital
- Double Bay Day Surgery
- Concord Repatriation General Hospital (Public)
Academic & Management Appointments
- Co-coordinator of CEPI5312: Diagnostic and Screening Tests Sydney School of Public Health, University of Sydney
- Senior Research Fellow, Gastrointestinal Group The Daffodil Centre, a joint venture of Cancer Council NSW and the University of Sydney.
Achievements and Awards
- 2017, Churchill Fellowship
- 2016, Prince of Wales Clinical School Travel Grant (2016)
- 2015, White-Walker UNSW & University of Oxford Cancer Research Scholarship
- 2015 ~ 2017, National Health and Medical Research Council (NHMRC) Postgraduate Scholarship, RG141797
- 2014, Prince of Wales Clinical School Postgraduate Research Scholarship
- 2010 & 2011, Best Registrar Teacher Award – Prince of Wales Clinical School
- 2011, Annual Coast Association TOW Research Awards Winner of the Case Presentation Award for Medicine
- 2009, nnual Coast Association TOW Research Awards Winner of the Case Presentation Award
Grogan P, He E, Pockney P. Improving colonoscopy prioritisation and promoting the National Bowel Cancer Screening Program: keys to reducing bowel cancer burden. Public Health Res Pract. 2023 Mar 15;33(1)
Worthington J, Lew JB, He E, Broun K, D’Onise K, Grogan P, Canfell K, Feletto E. The ‘hot zone policy’ for colorectal cancer screening presents unique risks and opportunities for rural Australia. Aust J Rural Health. 2023 Mar 13
Worthington J, He E, Lew JB, St John J, Horn C, Grogan P, Canfell K, Feletto E. Colonoscopies in Australia – how much does the National Bowel Cancer Screening Program contribute to colonoscopy use? Public Health Res Pract. 2023 Mar 15;33(1):32342216.
Yap S, He E, Egger S, Goldsbury DE, Lew JB, Ngo PJ, Worthington J, Rillstone H, Zalcberg JR, Cuff J, Ward RL, Canfell K, Feletto E, Steinberg J. Colon and rectal cancer treatment patterns and their associations with clinical, sociodemographic and lifestyle characteristics: analysis of the Australian 45 and Up Study cohort. BMC Cancer. 2023 Jan 18;23(1):60.
Steinberg J, Chan P, Hogden E, Tiernan G, Morrow A, Kang YJ, He E, Venchiarutti R, Titterton L, Sankey L, Pearn A, Nichols C, McKay S, Hayward A, Egoroff N, Engel A, Gibbs P, Goodwin A, Harris M, Kench JG, Pachter N, Parkinson B, Pockney P, Ragunathan A, Smyth C, Solomon M, Steffens D, Toh JWT, Wallace M, Canfell K, Gill A, Macrae F, Tucker K, Taylor N. Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitals. Hered Cancer Clin Pract. 2022 May 4;20(1):18.
Chan MV, Huo YR, Trieu N, Mitchelle A, George J, He E, Lee AU, Chang J, Yang J. Noncontrast MRI for Hepatocellular Carcinoma Detection: A Systematic Review and Meta-analysis – A Potential Surveillance Tool? Clin Gastroenterol Hepatol. 2022 Jan;20(1):44-56.e2.
Goldsbury DE, Feletto E, Weber MF, Haywood P, Pearce A, Lew JB, Worthington J, He E, Steinberg J, O’Connell DL, Canfell K. Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia. PLoS One. 2021 Nov 29;16(11):e0260088.
Lew JB, Greuter MJE, Caruana M, He E, Worthington J, St John DJ, Macrae FA, Feletto E, Coupé VMH, Canfell K. Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials. Med Decis Making. 2020 Aug;40(6):815-829.
Steinberg J, Chan P, Hogden E, Tiernan G, Morrow A, Kang YJ, He E, Venchiarutti R, Titterton L, Sankey L, Pearn A, Nichols C, McKay S, Hayward A, Egoroff N, Engel A, Gibbs P, Goodwin A, Harris M, Kench JG, Pachter N, Parkinson B, Pockney P, Ragunathan A, Smyth C, Solomon M, Steffens D, Toh JWT, Wallace M, Canfell K, Gill A, Macrae F, Tucker K, Taylor N. Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitals. Hered Cancer Clin Pract. 2022 May 4;20(1):18.
Feletto E, Lew JB, Worthington J, He E, Caruana M, Butler K, Hui H, Taylor N. Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia. BMJ Open 2020;10:e036475.
Lew JB, Greuter MJE, Caruana M, He E, Worthington J, St John DJ, Macrae FA, Feletto E, Coupé VMH, Canfell K. Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials. Medical Decision Making. 2020;40:815-29.
Blanks R, Burón Pust A, Alison R, He E, Barnes I, Patnick J, Reeves GK, Floud S, Beral V, Green J. Screen-detected and interval colorectal cancers in England: Associations with lifestyle and other factors in women in a large UK prospective cohort. International Journal of Cancer 2019;145:728-34
Lew JB, St John DJB, Macrae FA, Emery JD, Ee HC, Jenkins MA, He E, Grogan P, Caruana M, Sarfati D, Greuter MJE, Coupé VMH, Canfell K. Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia. International Journal of Cancer 2018;143:269-82.
Lew JB, St John DJB, Macrae FA, Emery JD, Ee HC, Jenkins MA, He E, Grogan P, Caruana M, Greuter MJE, Coupé VMH, Canfell K. Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia. Cancer Epidemiol Biomarkers Prevention 2018;27:1450-61.
He E, Alison R, Blanks R, Pirie K, Reeves G, Ward RL, Steele R, Patnick J, Canfell K, Beral V, Green J. Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England. International Journal of Epidemiology 2019;48:549-58.
He E, Lew JB, Egger S, Banks E, Ward RL, Beral V, Canfell K. Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort. Preventive Medicine 2018;106:185-93.
He EY, Wyld L, Sloane MA, Canfell K, Ward RL. The molecular characteristics of colonic neoplasms in serrated polyposis: a systematic review and meta-analysis. The Journal of Pathology Clinical Research 2016;2:127-37.
He EY, Hawkins NJ, Mak G, Roncolato F, Goldstein D, Liauw W, Clingan P, Chin M, Ward RL. The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study. The Oncologist 2016;21:618- 25.
Lew JB, St John DJB, Xu XM, Greuter MJE, Caruana M, Cenin DR, He E, Saville M, Grogan P, Coupé VMH, Canfell K. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study. The Lancet Public Health 2017;2:e331-e40.
Wang LW, He EY, Ghosh D, Day RO, Jones GR, Subbiah RN, Holloway CJ. Severe carbon monoxide poisoning from waterpipe smoking: a public health concern. The Medical Journal of Australia 2015;202:446-7.
He EY, Wang LW, Kiernan MC. Scurvy and stroke – is there an association? The Medical Journal of Australia 2010;193:555-6.
- Wang LW, He EY. Flexible working arrangements in prevocational training: implications for the delivery of safe and effective health care. Australian health review : a publication of the Australian Hospital Association 2010;34:49-51.
Cancer Council NSW (2021). Roadmap to Liver Cancer Control Scoping Review. Report produced for Cancer Council Australia
Appointments & Enquries
Our goal at Sydney Colorectal Associates is to deliver prompt access to appointments, diagnostic services and procedures that are tailored to your requirements.